Table 1.
Characteristics | No. |
---|---|
Lung cancer (N = 85) | |
Age, years; mean (range) | 62.1 (28–80) |
Gender (male/female) | 36/49 |
MTD,mm; mean (range) | 17 (5–30) |
Histology (number of patients) | |
ADC | 71 (83.5%) |
ACIS | 12 (16.9%) |
MIA | 25 (35.2%) |
ADI | 34 (47.9%) |
Adenosquamous cell carcinoma | 1 (1.2%) |
SCC | 6 (7.1%) |
LCC | 3 (3.5%) |
Small cell carcinoma | 1 (1.2%) |
Unknown | 3 (3.5%) |
Benign diseases (N = 46) | |
Age, years;mean (range) | 56.5 (23–85) |
Sex (male/female) | 21/25 |
MTD mm; mean (range) | 11.1 (3–30) |
Inflammatory nodules | 19 (41.3%) |
Hamartoma | 4 (8.7%) |
Pulmonary tuberculosis | 1 (2.2%) |
Inflammatory pseudotumour | 2 (4.3%) |
Lymph nodes | 1 (2.2%) |
Lipoma | 1 (2.2%) |
Granuloma | 1 (2.2%) |
Organized pneumonia | 1 (2.2%) |
Abscess | 1 (2.2%) |
Leiomyomata | 2 (4.3%) |
Fungal infection | 1 (2.2%) |
Others | 12 (26.1%) |
ADC adenocarcinoma; MTD maximum tumour diameter; ACIS adenocarcinoma in situ; MIA microinvasive adenocarcinoma; ADI adenocarcinoma infiltrating; SCC squamous cell carcinoma; LCC large cell carcinoma